Van ECK Associates Corp Sells 8,739 Shares of Humana Inc. $HUM

Van ECK Associates Corp lowered its position in shares of Humana Inc. (NYSE:HUM) by 69.9% during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 3,758 shares of the insurance provider’s stock after selling 8,739 shares during the quarter. Van ECK Associates Corp’s holdings in Humana were worth $1,493,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Johnson Financial Group Inc. bought a new position in Humana in the 2nd quarter valued at $26,000. Fideuram Asset Management Ireland dac bought a new stake in shares of Humana during the 4th quarter worth $27,000. Trust Co. of Vermont bought a new stake in shares of Humana during the 2nd quarter worth $28,000. Reflection Asset Management purchased a new position in shares of Humana in the 4th quarter worth about $29,000. Finally, Bogart Wealth LLC grew its position in Humana by 192.0% during the second quarter. Bogart Wealth LLC now owns 73 shares of the insurance provider’s stock valued at $29,000 after buying an additional 48 shares during the period. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Humana Price Performance

HUM opened at $400.70 on Friday. The firm has a 50-day moving average price of $388.44 and a 200-day moving average price of $296.00. Humana Inc. has a twelve month low of $163.11 and a twelve month high of $428.88. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.62. The company has a market capitalization of $48.12 billion, a price-to-earnings ratio of 37.91, a PEG ratio of 2.67 and a beta of 0.74.

Humana (NYSE:HUM) last announced its quarterly earnings results on Wednesday, July 29th. The insurance provider reported $7.61 EPS for the quarter, beating analysts’ consensus estimates of $7.27 by $0.34. Humana had a net margin of 0.88% and a return on equity of 11.20%. The company had revenue of $40.89 billion for the quarter, compared to analysts’ expectations of $40.58 billion. During the same period in the prior year, the company posted $6.27 EPS. Humana’s revenue was up 26.2% compared to the same quarter last year. Equities analysts expect that Humana Inc. will post 9 EPS for the current year.

Humana Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, November 27th. Stockholders of record on Friday, October 30th will be given a $0.885 dividend. The ex-dividend date is Friday, October 30th. This represents a $3.54 annualized dividend and a dividend yield of 0.9%. Humana’s payout ratio is 33.49%.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on HUM shares. Mizuho raised their price objective on shares of Humana from $335.00 to $390.00 and gave the stock an “outperform” rating in a report on Monday, June 8th. Morgan Stanley raised shares of Humana from an “underweight” rating to an “equal weight” rating and increased their target price for the company from $249.00 to $370.00 in a research report on Tuesday, August 4th. TD Cowen raised their price target on shares of Humana from $350.00 to $370.00 and gave the stock a “hold” rating in a research note on Friday, July 31st. Piper Sandler upgraded Humana from a “hold” rating to an “overweight” rating and set a $463.00 price objective on the stock in a research note on Thursday, July 30th. Finally, Zacks Research downgraded Humana from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, August 11th. Fourteen investment analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $403.91.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.